Neurochemical Research, 2023 · DOI: 10.1007/s11064-022-03720-y · Published: August 16, 2022
Spinal cord injury (SCI) leads to loss of motor and sensory functions, impacting life quality and creating a social burden. Long non-coding RNAs (LncRNAs) regulate neurological illnesses. Differentially expressed LncRNAs after SCI influence inflammatory damage, apoptosis, and nerve healing by acting as competitive endogenous RNA (ceRNA). LncRNAs, which are 200-1000 bp non-coding RNAs, have a key regulatory role in various neurological illnesses, including SCI. They can function as ceRNAs, affecting inflammatory damage, apoptosis, and nerve healing. They also significantly regulate neuropathic pain. LncRNAs could serve as molecular regulatory targets for diagnosing, treating, and predicting the outcome of spinal cord injuries. This review summarizes the regulatory role and molecular mechanism of LncRNAs in the development of spinal cord injury.
LncRNAs could potentially serve as biomarkers for the diagnosis of spinal cord injury.
Targeting LncRNAs may offer new therapeutic strategies for treating spinal cord injury.
LncRNA expression levels may predict the prognosis and recovery potential of spinal cord injury patients.